| Vincristine-induced peripheral neuropathy and urinary bladder paralysis in a child with rhabdomyosarcoma. | |
| | |
MedLine Citation:
|
PMID: 18176183 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Vincristine commonly induces peripheral neuropathy but rarely causes voiding dysfunction. In this report, we describe a case of neurogenic bladder and peripheral neuropathy caused by the neurotoxic effect of vincristine and documented by urodynamic testing and electromyography. Neurologic evaluation aided in monitoring and understanding this problem. |
| | |
Authors:
|
Elvan Caglar Citak; Aynur Oguz; Ceyda Karadeniz; Belgin Karaoglan; Mustafa Ozgur Tan; Visal Okur; Ali Cansu |
Related Documents
:
|
229503 - Depressed affect as a cause of associated somatic problems. 3101053 - Male infertility. 3. endocrine causes. 7633493 - Assortative mating in somatic traits and its consequences. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of pediatric hematology/oncology Volume: 30 ISSN: 1077-4114 ISO Abbreviation: J. Pediatr. Hematol. Oncol. Publication Date: 2008 Jan |
Date Detail:
|
Created Date: 2008-01-07 Completed Date: 2008-03-18 Revised Date: 2011-10-06 |
Medline Journal Info:
|
Nlm Unique ID: 9505928 Medline TA: J Pediatr Hematol Oncol Country: United States |
Other Details:
|
Languages: eng Pagination: 61-2 Citation Subset: IM |
Affiliation:
|
Department of Pediatric Oncology, Gazi University Faculty of Medicine, Besevler, Ankara, Turkey. caglarcitak@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antineoplastic Combined Chemotherapy Protocols
/
administration & dosage,
adverse effects* Child Cyclophosphamide / administration & dosage, adverse effects Dactinomycin / administration & dosage, adverse effects Electromyography Humans Male Monitoring, Physiologic Paralysis / chemically induced* Rhabdomyosarcoma / complications*, drug therapy Urinary Bladder, Neurogenic / chemically induced* Urodynamics Vincristine / administration & dosage, adverse effects* |
| Chemical | |
Reg. No./Substance:
|
50-18-0/Cyclophosphamide; 50-76-0/Dactinomycin; 57-22-7/Vincristine |
| Comments/Corrections | |
Comment In:
|
J Pediatr Hematol Oncol. 2008 Nov;30(11):869
[PMID:
18989167
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL.
Next Document: Hepatic veno-occlusive disease followed by esophageal varix rupture after hematopoietic stem cell tr...